Subacute Aspergillosis "Fungal Balls" Complicating COVID-19. 2020

Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
Maimonides Medical Center, Brooklyn, NY, USA.

Severe acute respiratory syndrome coronavirus-2 infection (SARS-CoV-2), commonly known as COVID-19 (coronavirus disease-2019), began in the Wuhan District of Hubei Province, China. It is regarded as one of the worst pandemics, which has consumed both human lives and the world economy. COVID-19 infection mainly affects the lungs triggering severe hypoxemic respiratory failure, also providing a nidus for superimposed bacterial and fungal infections. We report the case of a 73-year-old male who presented with progressive dyspnea; diagnosed with SARS-CoV-2-related severe acute respiratory distress syndrome and complicated with lung cavitations growing Aspergillus sp. COVID-19, to our knowledge, has rarely been associated with subacute invasive pulmonary aspergillosis with aspergillomas. Subacute invasive pulmonary aspergillosis as a superimposed infection in patients with SARS-CoV-2 is a rare entity. By reporting this case, we would like to make the readers aware of this association.

UI MeSH Term Description Entries
D008297 Male Males
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
January 2023, Clinical medicine insights. Case reports,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
January 2022, Mycoses,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
February 1980, The Journal of allergy and clinical immunology,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
January 2022, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
October 2021, Journal of fungi (Basel, Switzerland),
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
January 2022, Journal of fungi (Basel, Switzerland),
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
March 2021, Medical mycology case reports,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
September 2020, American journal of respiratory and critical care medicine,
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
January 2015, Allergy & rhinology (Providence, R.I.),
Ravi Karan Patti, and Nishil R Dalsania, and Navjot Somal, and Ankur Sinha, and Sanwal Mehta, and Monica Ghitan, and Chanaka Seneviratne, and Yizhak Kupfer
November 2020, Journal of fungi (Basel, Switzerland),
Copied contents to your clipboard!